. "Appendix A: Workshop Agenda." Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press, 2008.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Addressing the Barriers to Pediatric Drug Development: Workshop Summary
9:25 am
Relabeling of Existing Drugs
William Rodriguez, PhD, MD
U.S. Food and Drug Administration
9:40 am
Lessons Learned and Future Directions
Dianne Murphy, MD
U.S. Food and Drug Administration
9:55 am
Discussion
10:25 am
Break
Incentives and Disincentives for Pediatric Drug Development
10:40 am
Ethical Issues Concerning Testing of New Drugs in Children
Robert Nelson, MD, PhD
Children’s Hospital of Philadelphia
10:55 am
Natasha Jarrett
Hoffmann-LaRoche
11:10 am
Thomas Hassall, RPh, MS
Abbott Laboratories
11:25 am
Discussion
12:00 pm
Lunch
Dose Finding and Bioavailability Guessing
1:00 pm
Robert Ward, MD
University of Utah
1:15 pm
Best Pharmaceuticals for Children Act: Pediatric Formulation Issues
George Giacoia, MD
National Institute of Child Health and Human Development, National Institutes of Health
